SCHEMBL24399619

SCHEMBL24399619

CNc1c(C)ccc2c(Nc3ccc(Cl)cc3F)nccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDR P35968 10/20 0.46
▸ BRAF P15056 7/20 0.46
▸ LCK P06239 3/20 0.46
▸ TEK Q02763 3/20 0.46
▸ FLT1 P17948 7/20 0.46
▸ FGFR1 P11362 4/20 0.46
▸ FLT4 P35916 2/20 0.46
▸ EPHB2 P29323 1/20 0.46
▸ EGFR P00533 3/20 0.41
▸ NUDT1 P36639 2/20 0.40
▸ RAF1 P04049 4/20 0.40
▸ CSF1R P07333 2/20 0.40
▸ DDR1 Q08345 2/20 0.40
▸ DDR2 Q16832 2/20 0.40
▸ SRC P12931 2/20 0.39
▸ ERBB2 P04626 1/20 0.39
▸ IGF1R P08069 1/20 0.39
▸ EPHB4 P54760 1/20 0.39
▸ AURKB Q96GD4 1/20 0.39
▸ ARAF P10398 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26207944 0.84 KDR (0.46) KDRBRAFLCKTEKFLT1
SCHEMBL25376089 0.80 KDR (0.43) KDRBRAFTEKFLT1FGFR1
SCHEMBL29123741 0.79 KDR (0.42) KDRBRAFLCKTEKFLT1
SCHEMBL24399614 0.76 ADORA2A (0.46) KDRBRAFLCKTEKFLT1
SCHEMBL15069866 0.75 BRAF (0.42) KDRBRAFLCKTEKFLT1
SCHEMBL29638613 0.74 BRAF (0.61) BRAFNUDT1RAF1CSF1RDDR1
SCHEMBL24399766 0.74 BRAF (0.46) KDRBRAFLCKTEKRAF1
SCHEMBL2519930 0.74 BRAF (0.77) KDRBRAFLCKTEKFGFR1
SCHEMBL15066194 0.73 BRAF (0.78) KDRBRAFFLT1FGFR1RAF1
SCHEMBL26209706 0.72 DHODH (0.41) KDRBRAFFLT1FGFR1EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022089219-A1 ARYLAMIDE COMPOUND, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND PREPARATION METHOD THEREFOR AND USE THEREOF 四川科伦博泰生物医药股份有限公司 2022-05-05 — — WO disclosed
Send feedback